Several European and American research institutions and commercial firms have reported progress recently. New therapies have emerged to treat the critical window between acute and chronic pain. Neurotech Reports editors released their latest forecasts for the SCS and PNS markets through the end of the decade. The procedure was performed in Rotterdam. Cognito Therapeutics Moves Forward with Commercialization. Neurotech Entrepreneurs Make Presentations at LSI USA 25. Pitt Ophthalmologist Makes Headway in BCI Research. Neurotech and PsychiatryMarch 2025 Issue
Neuroprosthetics Applications Continue to Evolve
Neuromodulation Solutions Target “Transitional” Pain
Implanted Pain Neuromodulation Market to Reach $6.5B
Salvia BioElectronics Announces First Implant in Holland
Vendor Profile
Conference Report
Research Institution Profile
Commentary
Financial News
News Briefs
Research Highlights